WWM
DMK

Wolff Wiese Magana’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Wolff Wiese Magana’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-145
Closed -$102 – 755
2023
Q4 		$102 Sell
145
-6
-4% -$3 ﹤0.01% 696
2023
Q3 		$105 Hold
151
– – ﹤0.01% 772
2023
Q2 		$364 Sell
151
-2
-1% -$9 ﹤0.01% 723
2023
Q1 		$1.25K Hold
153
– – ﹤0.01% 562
2022
Q4 		$1.82K Hold
153
– – ﹤0.01% 513
2022
Q3 		$2K Hold
153
– – ﹤0.01% 729
2022
Q2 		$5K Hold
153
– – ﹤0.01% 648
2022
Q1 		$6K Hold
153
– – ﹤0.01% 625
2021
Q4 		$6K Hold
153
– – ﹤0.01% 617
2021
Q3 		$10K Hold
153
– – 0.01% 528
2021
Q2 		$12K Hold
153
– – 0.01% 478
2021
Q1 		$10K Hold
153
– – 0.01% 485
2020
Q4 		$5K Buy
+153
New +$6.81K ﹤0.01% 550

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Wolff Wiese Magana's DMK Position: Q1 2024 in Review

Wolff Wiese Magana sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 145 shares — an estimated $102 sold.

Wolff Wiese Magana first reported a position in DMK in Q4 2020 and held it in 13 quarters. The position peaked at $12K in Q2 2021. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Wolff Wiese Magana reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wolff Wiese Magana sold 145 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $102.
  • Wolff Wiese Magana first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2020 and held it in 13 quarters.
  • Wolff Wiese Magana's DMK Pharmaceuticals Corporation Common Stock position peaked at $12K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Wolff Wiese Magana's 13F filing for Q1 2024, filed 18 Apr 2024.